José Ramón
Caeiro Rey
Eli Lilly and Company
Indianapolis, EE. UU.Publications in collaboration with researchers from Eli Lilly and Company (3)
2017
-
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial
Journal of Bone and Mineral Research, Vol. 32, Núm. 5, pp. 1040-1051
2016
-
Effects of teriparatide compared with risedronate on recovery after pertrochanteric hip fracture results of a randomized, active-controlled, double-blind clinical trial at 26 weeks
Journal of Bone and Joint Surgery - American Volume, Vol. 98, Núm. 22, pp. 1868-1878
-
Effets du tériparatide et du risédronate sur la DMO et la consolidation fracturaire chez des patients âgés avec fracture pertrochantérique récente: Résultats finaux d'un essai clinique randomisé de 78 semaines
Revue du Rhumatisme (Edition Francaise), Vol. 83, pp. A83-A84